NCT02734433View on ClinicalTrials.gov

Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 13, 2017

Study Completion Date

May 28, 2021

Conditions
Advanced Solid Tumors
Interventions
DRUG

Pexidartinib

Trial Locations (1)

Unknown

Taipei

Sponsors
All Listed Sponsors
lead

Daiichi Sankyo Co., Ltd.

INDUSTRY